Legend Biotech (LEGN) Tops Q4 EPS by 9c

Legend Biotech (NASDAQ: LEGN) reported Q4 EPS of ($0.16), $0.09 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $186.52 million versus the consensus estimate of $173.99 million.

For earnings history and earnings-related data on Legend Biotech (LEGN) click here.

You May Also Be Interested In

• Texas Instruments (TXN) Reiterated at Neutral by Cantor Fitzgerald on Upside to Earnings Power
• Washington Federal (WAFD) PT Lowered to $37 at DA Davidson
• BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel